MedPath

Effects of quince fruit syrup on reduction of cardiotoxicity induced by Herceptin in patients with breast cancer

Phase 1
Conditions
Patients with breast cancer who are taking herceptin.
Registration Number
IRCT20200427047219N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
30
Inclusion Criteria

Breast cancer in the early stages of the disease
HER2 positive
Women over 18 years
Lack of underlying heart problems
The desire to participate in the study

Exclusion Criteria

Suffering from other cancers
Thyroid disorders
Kidney disorders
Getting other vitamin or mineral supplements
Patients with lower body mass index18/5
Lack of desire to continue participating in the project

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath